Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
KPL.BOthis companyKwality Pharmaceuticals Limited	₹3,856.75	20.13×	4.09×	2.69×	12.56×	-80.9%	33.9%	19.6%	13.4%	20.3%	15.8%	-2.9%	0.39×	1.1×	8.97×	1.8×	0.0%	4	—	2	C
BDH.BOBDH Industries Limited	₹414.55	18.78×	2.64×	2.12×	10.9×	99.9%	18.4%	13.6%	11.3%	14.0%	11.4%	-0.1%	0.03×	-1.7×	213.65×	4×	1.3%	4	—	2	B-
CONCORD.BOConcord Drugs Limited	₹72.72	83.11×	1.8×	1.11×	22.15×	-217.1%	14.1%	4.0%	1.3%	2.2%	3.5%	-9.1%	0.28×	2.93×	1.86×	2.53×	0.0%	4	—	2	C
FDC.NSFDC Limited	₹394.20	18.57×	2.1×	2.41×	11.83×	14.1%	42.3%	13.2%	13.0%	11.3%	8.4%	1.2%	0.01×	-0.08×	57.54×	3.11×	1.6%	3	8.69	4	A
KILITCH.NSKilitch Drugs (India) Limited	₹200.54	13.97×	1.51×	1.79×	10.31×	-261.5%	38.8%	14.0%	12.8%	10.8%	6.9%	-19.1%	0.32×	1.5×	5.93×	1.83×	0.0%	2	—	2	C+
MEDICAMEQ.NSMedicamen Biotech Limited	₹279.55	30.93×	1.08×	1.51×	13.86×	-99.3%	27.3%	6.3%	4.9%	3.5%	3.1%	-13.3%	0.17×	0.73×	3.54×	2.54×	0.5%	4	—	2	C+
Peer median	—	18.78×	1.8×	1.79×	11.83×	-99.3%	27.3%	13.2%	11.3%	10.8%	6.9%	-9.1%	0.17×	0.73×	5.93×	2.54×	0.5%	4	8.69	2	—